Although CD24 up-regulation has been previously correlated with tumor progression, invasiveness, differentiation, and chemotherapy resistance [46,47,48], its role in modulating the CRC stem cell phenotype remains inconclusive. This evidence concerns the gene CD24 and colorectal carcinoma.